ImageneBio (IMA) FCF Margin (2020 - 2025)

ImageneBio has disclosed FCF Margin across 6 years of filings, most recently posting 903.75% for Q1 2025.

• FCF Margin for Q1 2025 came in at 903.75%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was 568.52% (changed N/A YoY), and the FY2023 annual result was 875.08%, down 39891.0% from the prior year.
• FCF Margin came in at 903.75% for Q1 2025 at ImageneBio, down from 370.34% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 370.34% in Q3 2024 to a low of 5101.31% in Q2 2022.
• The 5-year median for FCF Margin is 461.35% (2021), against an average of 1036.65%.
• Across the five-year window, FCF Margin surged 2024560 bps in 2021 and sank 463377 bps in 2022, its largest moves.
• ImageneBio's FCF Margin stood at 74.4% in 2021, then slumped by 312 bps to 306.68% in 2022, then plunged by 993 bps to 3350.68% in 2023, then soared by 111 bps to 370.34% in 2024, then plunged by 344 bps to 903.75% in 2025.
• The last three FCF Margin figures came in at 903.75% (Q1 2025), 370.34% (Q3 2024), and 3350.68% (Q4 2023), per Business Quant data.